Bharti, Nikhil http://orcid.org/0000-0002-4068-0325
Santos, Leonardo
Davyt, Marcos
Behrmann, Stine
Eichholtz, Marie
Jimenez-Sanchez, Alejandro http://orcid.org/0000-0001-7351-190X
Hong, Jeong S.
Rab, Andras http://orcid.org/0000-0003-2154-0017
Sorscher, Eric J. http://orcid.org/0000-0001-9341-3354
Albers, Suki http://orcid.org/0000-0002-4972-5577
Ignatova, Zoya http://orcid.org/0000-0002-9478-8825
Funding for this research was provided by:
Cystic Fibrosis Foundation (IGNATO2010)
Article History
Received: 20 September 2023
Accepted: 20 March 2024
First Online: 5 April 2024
Competing interests
: Z.I., S.A., N.B., and M.D. are inventors of patents related to tRNA designs for PTC correction. Z.I. is also a scientific advisor for Tevard Biosciences. E.J.S. is a non-voting trustee for the Cystic Fibrosis Foundation. The other authors declare no competing interests.